Correlation Between PDS Biotechnology and Syros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Syros Pharmaceuticals, you can compare the effects of market volatilities on PDS Biotechnology and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Syros Pharmaceuticals.
Diversification Opportunities for PDS Biotechnology and Syros Pharmaceuticals
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between PDS and Syros is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Syros Pharmaceuticals go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Syros Pharmaceuticals
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 0.25 times more return on investment than Syros Pharmaceuticals. However, PDS Biotechnology Corp is 4.03 times less risky than Syros Pharmaceuticals. It trades about -0.27 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 319.00 in PDS Biotechnology Corp on September 1, 2024 and sell it today you would lose (100.00) from holding PDS Biotechnology Corp or give up 31.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Syros Pharmaceuticals
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Syros Pharmaceuticals |
PDS Biotechnology and Syros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Syros Pharmaceuticals
The main advantage of trading using opposite PDS Biotechnology and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Syros Pharmaceuticals vs. Tff Pharmaceuticals | Syros Pharmaceuticals vs. Eliem Therapeutics | Syros Pharmaceuticals vs. Inhibrx | Syros Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |